Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
160 participants
INTERVENTIONAL
2016-04-12
2016-12-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trima Non-DEHP Leukoreduced Red Blood Cell In Vivo Recovery Study
NCT06602804
Accuracy Performance Verification of the INVOS™ System in Pediatrics
NCT05962905
TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning
NCT05743842
An In Vivo 24-Hour Recovery Study of Whole Blood by the Reveos System
NCT05239455
Evaluation of Trima Version 7.0 Platelets in 100% Plasma
NCT02754492
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A- Control
Group A will have their PIVs assessed daily and record kept of PIV dislodgement or replacement
No interventions assigned to this group
B - Device Intervention
patients will have their PIVs assessed daily and record kept of PIV displodgement or replacement. patients will additionally have a single blood collection attempted using the study device
TIVA blood collection device
the device is attached to a peripheral IV catheter for use as a direct blood draw device into a vacuum tube or a syringe
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TIVA blood collection device
the device is attached to a peripheral IV catheter for use as a direct blood draw device into a vacuum tube or a syringe
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is at least 18 years old
* Patient is willing and physically / cognitively able to sign a written consent form
* Patient is willing and able to complete study questionnaires
* Patient is NOT a prisoner
Exclusion Criteria
* Hemolytic disorders (e.g., sickle cell disease)
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Velano Vascular, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Deborah F Mulloy, PhD, RN
Role: PRINCIPAL_INVESTIGATOR
Brigham and Women's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brigham and Women's Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.